State Street SPDR S&P Biotech ETF (XBI) Dividend Yield, History & Forecast

State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 0.36% ($0.54 per share annually (TTM)). The most recent ex-dividend date was June 22, 2026, with payment scheduled for June 24, 2026. market capitalization is approximately $7.55B. Review XBI dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

Loading quote...

XBI fund composition

XBI holds 165 positions, with 17.9% of assets in its ten largest. It charges an expense ratio of 0.35%, and manages $9.88B.

Top 10 holdings

HoldingWeight
MRNAMODERNA INC2.56%
NTRANATERA INC1.85%
HALOHALOZYME THERAPEUTICS INC1.75%
ABBVABBVIE INC1.73%
TWSTTWIST BIOSCIENCE CORP1.71%
BIIBBIOGEN INC1.70%
AMGNAMGEN INC1.66%
IOVAIOVANCE BIOTHERAPEUTICS INC1.66%
EXELEXELIXIS INC1.65%
UTHRUNITED THERAPEUTICS CORP1.64%

Sector allocation

Healthcare99.3%Financial Services0.7%Cash & Others0.2%

Compare XBI

Yield, fees, returns and holdings overlap, side by side.

Frequently Asked Questions about State Street SPDR S&P Biotech ETF (XBI)

What is State Street SPDR S&P Biotech ETF's dividend yield?
State Street SPDR S&P Biotech ETF (XBI) pays a current trailing twelve-month dividend yield of 0.36%, which works out to $0.54 per share annually based on the most recent payout schedule.
When does State Street SPDR S&P Biotech ETF pay its next dividend?
The most recent ex-dividend date was June 22, 2026. The next scheduled dividend payment date is June 24, 2026.
How many years has State Street SPDR S&P Biotech ETF increased its dividend?
State Street SPDR S&P Biotech ETF (XBI) has increased its dividend for 2 consecutive years.
Is State Street SPDR S&P Biotech ETF a Dividend Aristocrat?
No. Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. State Street SPDR S&P Biotech ETF (XBI) currently has 2 years of consecutive increases.
What sector is State Street SPDR S&P Biotech ETF in?
State Street SPDR S&P Biotech ETF (XBI) operates in the Financial Services sector, specifically the Asset Management industry.